ArticleCancer letters2024

Combined inhibition of CDK4/6 and AKT is highly effective against the luminal androgen receptor (LAR) subtype of triple negative breast cancer.

María Rosario Chica-Parrado et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.